Meditera Tibbi Malzeme Sanayi ve Ticaret AS
MEDTR.IS
| Exchange: | IS |
| Currency | Turkish lira |
| ISIN: | TREMDTR00028 |
| Primary Ticker: | MEDTR.IS |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Medical Devices |
| Gic Sector: | Health Care |
| Gic Group: | Health Care Equipment & Services |
| Gic Industry: | Health Care Equipment & Supplies |
| Gic Sub Industry: | Health Care Equipment |
| Description: | Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers breathing sytems products, including breathing circuits, breathing filters, catheter mounts, gas sampling lines, accessories, masks, and connectors. It also provides hospital products, such as barrier cream, surgical hand brushes for skin disinfection, hand and skin antiseptics, and skin and mucosa antiseptics. In addition, the company engages in the manufacturing and sale of anesthesia and intensive care circuits; installation, operation, and design of oncology drug preparation and delivery systems; production, sales, and technical service of infusion pumps and sets; and manufacturing of biocidal products. It also exports its products to 80 countries under its Altech brand name. Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi was founded in 1983 and is headquartered in Izmir, Turkey. |
| Address: | Ibni Melek OSB Mahallesi, TOSBI Yol 4, Izmir, Turkey, 35900 |
| Website: | https://www.meditera.com.tr |
| Full Time Employees: | 767 |
| Updated On: | 2024-11-09 |
Highlights
| Market Capitalization: | 6080899584 |
| Market Capitalization Mln: | 6080.89 |
| EBITDA: | 372595360 |
| Book Value: | 12.38 |
| Dividend Share: | 0.29 |
| Earnings Share: | -0.1 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.05 |
| Operating Margin TTM: | 0.22 |
| Return On Assets TTM: | 0.11 |
| Return On Equity TTM: | 0.06 |
| Revenue TTM: | 1499970176 |
| Revenue Per Share TTM: | 12.60 |
| Quarterly Revenue Growth YOY: | 0.12 |
| Gross Profit TTM: | 359598146 |
| Diluted Eps TTM: | -0.1 |
| Quarterly Earnings Growth YOY: | 0.63 |
Valuation
| Price Sales TTM: | 4.05 |
| Price Book MRQ: | 3.23 |
| Enterprise Value: | 5748796609 |
| Enterprise Value Revenue: | 4.11 |
| Enterprise Value Ebitda: | 69.22 |
Shares
| Shares Outstanding: | 119000000 |
| Shares Float: | 24454500 |
| Percent Insiders: | 79.45 |
| Percent Institutions: | 5.29 |
Technicals
| Beta: | 0.59 |
| 52 Week High: | 53 |
| 52 Week Low: | 24.18 |
| 50 Day MA: | 44.37 |
| 200 Day MA: | 37.54 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.29 |
| Payout Ratio: | 1.36 |
| Ex Dividend Date: | 2024-10-23 |
| Last Split Factor: | 350:100 |
| Last Split Date: | 2022-02-22 |
Earnings
| Report Date: | 2024-06-30 |
| Date: | 2024-06-30 |
| Currency: | TRY |
| Eps Actual: | 0.22 |
| Report Date: | 2024-03-31 |
| Date: | 2024-03-31 |
| Currency: | TRY |
| Eps Actual: | 0.08 |
| Report Date: | 2023-12-31 |
| Date: | 2023-12-31 |
| Currency: | TRY |
| Eps Actual: | -2.05 |
| Report Date: | 2023-09-30 |
| Date: | 2023-09-30 |
| Currency: | TRY |
| Eps Actual: | 1.01 |
| Report Date: | 2023-06-30 |
| Date: | 2023-06-30 |
| Currency: | TRY |
| Eps Actual: | 0.83 |
| Report Date: | 2022-12-31 |
| Date: | 2022-12-31 |
| Currency: | TRY |
| Eps Actual: | 0.49 |
| Report Date: | 2022-09-30 |
| Date: | 2022-09-30 |
| Currency: | TRY |
| Eps Actual: | 0.61 |
| Report Date: | 2022-06-30 |
| Date: | 2022-06-30 |
| Currency: | TRY |
| Eps Actual: | 0.79 |
| Report Date: | 2022-03-31 |
| Date: | 2022-03-31 |
| Currency: | TRY |
| Eps Actual: | 0.58 |
| Report Date: | 2021-12-31 |
| Date: | 2021-12-31 |
| Currency: | TRY |
| Eps Actual: | 1.02 |
| Report Date: | 2021-09-30 |
| Date: | 2021-09-30 |
| Currency: | TRY |
| Eps Actual: | 0.15 |
| Date: | 2024-06-30 |
| Eps Actual: | 0.31 |
| Date: | 2023-12-31 |
| Eps Actual: | -0.21 |
| Date: | 2022-12-31 |
| Eps Actual: | 2.49 |
| Date: | 2021-12-31 |
| Eps Actual: | 1.17 |